| Name | Title | Contact Details |
|---|---|---|
Erin Crider |
Head of Delivery and Recruitment Operations | Profile |
TICA group middle east is the branch and after-sale service center of TICA Air condition in the middle east, TICA is one of the leading manufacturers of HVAC (Heating, Ventilation and Air Conditioning) equipment in the world. #HVAC #VRF #CHILLER #DX
The Enoch Pratt Free Library is one of the oldest free public library systems in the United States. We serve the residents of Baltimore with branches throughout the city, and the residents of Maryland as the State Library Resource Center. Our mission is to provide equal access to information and services that empower, enrich, and enhance the quality of life for all. http://www.prattlibrary.org/jobs
AMB Sports and Entertainment, based in Atlanta, Georgia, is a dynamic organization under the Blank Family of Businesses, led by entrepreneur Arthur Blank. The company manages a diverse portfolio that includes professional sports teams, venues, and retail operations. Key components of AMB Sports and Entertainment include the NFLs Atlanta Falcons, the MLSs Atlanta United FC, and the Atlanta Drive GC, which is set to debut in the Tomorrow Golf League in 2025. The company operates the Mercedes-Benz Stadium, a versatile venue for sports and major events, and The Home Depot Backyard, an outdoor space for community activities. Additionally, it runs the PGA TOUR Superstore, a nationwide golf retail chain. AMBSE Ventures focuses on strategic investments in sports technology and entertainment. The organization is committed to community engagement through various initiatives, including diversity programs and large-scale events. With a dedicated leadership team and a growing workforce, AMB Sports and Entertainment continues to enhance its impact in the sports and entertainment landscape.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.